Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents.
作者信息
Van Praet Jens T, Vandecasteele Stefaan, De Roo Anneleen, De Vriese An S, Reynders Marijke
机构信息
Department of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
出版信息
Clin Infect Dis. 2021 Dec 6;73(11):2145-2147. doi: 10.1093/cid/ciab300.
Abstract
摘要
相似文献
1
Humoral and Cellular Immunogenicity of the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Nursing Home Residents.BNT162b2信使核糖核酸2019冠状病毒病疫苗在疗养院居民中的体液免疫原性和细胞免疫原性
Clin Infect Dis. 2021 Dec 6;73(11):2145-2147. doi: 10.1093/cid/ciab300.
2
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）-初治疗养院居民中 BNT162b2 信使 RNA 疫苗反应降低。
Clin Infect Dis. 2021 Dec 6;73(11):2112-2115. doi: 10.1093/cid/ciab447.
3
Cellular and Humoral Response, Six Months After Two Doses of BNT162b2 Messenger Ribonucleic Acid Coronavirus Disease 2019 Vaccination, in Residents and Staff of Nursing Homes for the Elderly.针对老年人的养老院居民和工作人员，在接种两剂BNT162b2信使核糖核酸2019冠状病毒病疫苗六个月后的细胞和体液反应
J Infect Dis. 2022 Jan 18;225(2):355-357. doi: 10.1093/infdis/jiab546.
4
Dynamics of the Cellular and Humoral Immune Response After BNT162b2 Messenger Ribonucleic Acid Coronavirus Disease 2019 (COVID-19) Vaccination in COVID-19-Naive Nursing Home Residents.新型冠状病毒肺炎（COVID-19）疫苗接种初免的养老院居民接种BNT162b2信使核糖核酸疫苗后细胞免疫和体液免疫反应的动态变化
J Infect Dis. 2021 Nov 22;224(10):1690-1693. doi: 10.1093/infdis/jiab458.
5
Single Dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Vaccine Is Associated With Lower Nasopharyngeal Viral Load Among Nursing Home Residents With Asymptomatic Coronavirus Disease 2019 (COVID-19).mRNA 单价 SARS-CoV-2 疫苗接种一剂可降低无症状 2019 冠状病毒病（COVID-19）养老院居民鼻咽部病毒载量。
Clin Infect Dis. 2021 Sep 15;73(6):e1365-e1367. doi: 10.1093/cid/ciab263.
6
Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.BNT162b2 mRNA新冠疫苗接种后发生的嗜酸性粒细胞性蜂窝织炎
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e26-e28. doi: 10.1111/jdv.17685. Epub 2021 Oct 5.
7
BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease Severity.BNT162b2 信使 RNA 疫苗未能预防老年疗养院严重急性呼吸综合征冠状病毒 2 变异株 501Y.V2 的爆发，但降低了传播和疾病严重程度。
Clin Infect Dis. 2022 Feb 11;74(3):517-520. doi: 10.1093/cid/ciab446.
8
Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine.BNT162b2 mRNA新冠疫苗注射部位的皮肤溃疡
J Dermatol. 2021 Dec;48(12):e596-e597. doi: 10.1111/1346-8138.16163. Epub 2021 Sep 21.
9
Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.比较未感染过严重急性呼吸综合征冠状病毒2（SARS-CoV-2）和既往感染过的疗养院居民对BNT162b2 mRNA疫苗接种的特异性抗体反应。
J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.011. Epub 2021 Oct 20.
10
Re: Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.关于：接种BNT162b2 mRNA新冠疫苗的孕妇的短期结局
Ultrasound Obstet Gynecol. 2021 Dec;58(6):958. doi: 10.1002/uog.24811.
引用本文的文献
1
Longitudinal Comparison of Three T-Cell Assays and Three Antibody Assays Against SARS-CoV-2 Following Homologous mRNA-1273/mRNA-1273/mRNA-1273 and Heterologous ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naïve Healthcare Workers.针对同源mRNA-1273/mRNA-1273/mRNA-1273和异源ChAdOx1/ChAdOx1/BNT162b2疫苗接种后三种T细胞检测和三种抗SARS-CoV-2抗体检测的纵向比较：一项针对未接种过疫苗的医护人员的前瞻性队列研究
Vaccines (Basel). 2024 Nov 29;12(12):1350. doi: 10.3390/vaccines12121350.
2
Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents-Georgia, October 2020-July 2022.养老院居民中感染 SARS-CoV-2 和接种 COVID-19 疫苗的免疫反应动力学 - 乔治亚州，2020 年 10 月至 2022 年 7 月。
PLoS One. 2024 Apr 16;19(4):e0301367. doi: 10.1371/journal.pone.0301367. eCollection 2024.
3
Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study.美国接种疫苗成年人中与SARS-CoV-2刺突1抗体反应相关的人口统计学和临床因素：C4R研究
Nat Commun. 2024 Feb 19;15(1):1492. doi: 10.1038/s41467-024-45468-9.
4
Investigating the impact of prior COVID-19 on IgG antibody and interferon γ responses after BBIBP-CorV vaccination in a disease endemic population: A prospective observational study.在疾病流行人群中研究既往新冠病毒病（COVID-19）对接种BBIBP-CorV疫苗后IgG抗体和干扰素γ反应的影响：一项前瞻性观察性研究。
Health Sci Rep. 2023 Sep 8;6(9):e1521. doi: 10.1002/hsr2.1521. eCollection 2023 Sep.
5
Covid-19 vaccines elicit effective IgG responses in an elderly thymus cancer patient with chemotherapy.Covid-19 疫苗在接受化疗的老年胸腺癌患者中引发有效的 IgG 应答。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2188035. doi: 10.1080/21645515.2023.2188035. Epub 2023 Apr 16.
6
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment.基于干扰素-γ释放试验，新冠病毒疫苗加强针可维持接受抗TNFα治疗的炎症性肠病（IBD）患者的T细胞免疫反应。
Vaccines (Basel). 2023 Mar 3;11(3):591. doi: 10.3390/vaccines11030591.
7
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination.评价 SARS-CoV-2 感染和接种疫苗后，QuantiFERON SARS-CoV-2 干扰素-γ 释放检测。
Clin Exp Immunol. 2023 Jun 5;212(3):249-261. doi: 10.1093/cei/uxad027.
8
Serological Responses up to 9 Months following COVID-19 mRNA Vaccination in Residents and Health-Care Workers of Long-Term Care Facilities: A Multicenter Prospective Cohort Study in Northern Italy.长期护理机构居民和医护人员接种新冠病毒mRNA疫苗后9个月内的血清学反应：意大利北部的一项多中心前瞻性队列研究
Vaccines (Basel). 2022 Dec 19;10(12):2183. doi: 10.3390/vaccines10122183.
9
Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.肠道炎症中 SARS-CoV-2 免疫的全身和 T 细胞相关反应（STAR SIGN 研究）：生物制剂对 mRNA 疫苗第三剂预防 SARS-CoV-2 效果的影响。
Aliment Pharmacol Ther. 2023 Jan;57(1):103-116. doi: 10.1111/apt.17264. Epub 2022 Oct 28.
10
Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.西弗吉尼亚州养老院队列中 COVID-19 疫苗接种后 SARS-CoV-2 抗体水平的持久性和保护潜力。
JAMA Netw Open. 2022 Sep 1;5(9):e2231334. doi: 10.1001/jamanetworkopen.2022.31334.
Zotero 插件